Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CP101”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Large-scale testing (Phase 3)Ended earlyNCT05153499
What this trial is testing

A Trial of CP101 for the Prevention of Recurrent CDI (PRISM4)

Who this might be right for
Recurrent C. Difficile Infection
Finch Research and Development LLC. 19
Testing effectiveness (Phase 2)Study completedNCT03110133
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Recurrent C. Diff

Who this might be right for
Clostridium Difficile Infection Recurrence
Finch Research and Development LLC. 206
Early research (Phase 1)Active Not RecruitingNCT05852574
What this trial is testing

CP101 for the Treatment of Ulcerative Colitis

Who this might be right for
Ulcerative Colitis
Brigham and Women's Hospital 30
Very early researchLooking for participantsNCT05516472
What this trial is testing

Fecal Microbiota Transplantation in Kidney Stone Patients

Who this might be right for
Kidney Stones
Joshua Stern 36
Testing effectiveness (Phase 2)Study completedNCT03497806
What this trial is testing

Open-Label Extension of CP101 Trials Evaluating Oral Full-Spectrum Microbiota™ (CP101) in Subjects With Recurrence of Clostridium Difficile Infection

Who this might be right for
Clostridium Difficile InfectionRecurrent Clostridium Difficile InfectionC. Diff+8 more
Finch Research and Development LLC. 132
Testing effectiveness (Phase 2)WithdrawnNCT03829878
What this trial is testing

Efficacy, Safety, and Tolerability Study of Oral Full-Spectrum MicrobiotaTM (CP101) in Subjects With Autism Spectrum Disorder and Associated GI Symptoms (SPROUT)

Who this might be right for
Autism Spectrum DisorderAutismASD+8 more
Finch Research and Development LLC.